Isoxazole and thiazole compounds and use thereof as medicine

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C514S380000, C514S340000, C514S236800, C546S272100, C544S137000, C548S214000, C548S245000

Reexamination Certificate

active

06964975

ABSTRACT:
The present invention relates to novel isoxazole and thiazole compounds having an excellent lysophosphatidic acid (LPA) receptor antagonistic activity represented by general formula [1] or salts thereof:wherein R1 and R2 represents an optionally substituted alkyl group or the like; R3 represents a hydrogen atom or the like; R4 represent a group selected from the group consisting of (I) optionally substituted phenyl, aryl, or heterocycle, (II) substituted or nonsubstituted alkyl, and (III) substituted or nonsubstituted alkenyl, alternatively, R3 and R4 may form a ring structure together with a carbon atom to which they bind; and X represents an oxygen atom or a sulfur atom, provided that, when R3 is a hydrogen atom, R4 represents a group other than methyl, and the use thereof as a medicine.

REFERENCES:
patent: 5861359 (1999-01-01), Theodoridis
patent: 6403791 (2002-06-01), Dyke et al.
patent: WO 95/13075 (1995-05-01), None
patent: WO 98/27213 (1998-06-01), None
patent: WO 01/34573 (2001-05-01), None
Drummond et al., J. Med. Chem. (1989), 32(9), pp. 2116-2128.
CA Registry No. 261714-80-1, entry date in Registry file is Apr. 12, 2000.
CA Registry No. 261714-57-2, entry date in Registry file is Apr. 12, 2000.
CA Registry No. 261622-75-7, entry date in Registry file is Apr. 11, 2000.
CA Registry No. 257284-80-3, entry date in Registry file is Feb. 29, 2000.
Reiter, Journal of Organic Chemistry (1987), 52(13), pp. 2714-2726.
Pharmazie, 1994, vol. 49, No. 10, pp. 727-729.
Database Crossfire Beilstein *Online! Beilstein Institut zur Forderung der Chemischen Wissenschaften, Frankfurt am Main, DE; Database accession No. 997021 XP002232339, 3,5-dimethyl-4 benzyloxycarbonylamino-isothiazole *abstract* & Indian J. Chem., vol. 7, 1969, pp. 103-105.
Database Crossfire Beilstein *Online! Beilstein institut zur Forderung der Chemischen Wissenschaften, Frankfurt am Main, DE; Database accession No. 920183 XP002232340 (5-methyl-3-phenyl-isoxazole-4-yl)- carbamic acid ethyl ester *abstact* & Pharm Chem. J., vol.7, 1968, pp. 388-389.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Isoxazole and thiazole compounds and use thereof as medicine does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Isoxazole and thiazole compounds and use thereof as medicine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Isoxazole and thiazole compounds and use thereof as medicine will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3478782

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.